CompoAtlas

UROFYT

Food supplement declared in France, decision dated 17 March 2026

UROFYT (Farmafyt) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 2 rules of use apply to its ingredients (limits and warnings).

Brand
Farmafyt
Food business operator placing the product on the market
Farmafyt
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Comprimé
Daily dose
2 x 1 comprimé par jour
Directions for use
Prendre 2 x 1 comprimés par jour avec beaucoup d’eau (250 ml), 1 le matin et 1 le soir.
Intended populations
Homme
Not recommended for (according to the manufacturer)
Enfants en bas âge (1 à 3 ans)
Objectives stated by the manufacturer (these are not authorised claims)
Système urinaire

Declaration 359831, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Serenoa repens (W.Bartram) SmallFruitExtrait sec hydroalcoolique160 mg
Urtica dioica L.RacineExtrait sec hydroalcoolique150 mg

Substances

NamePer day
quercétine200 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg

Additives

E1521, E466, E468, E141, E170, E464, E904, E570, E341, E551, E322, E463, E460

Other ingredients

maltodextrine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : Farmafyt

Enter to analyse, Shift+Enter for a new line